Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 2004; 97(Suppl 44): 26–35.
PMCID: PMC1308796

Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?


The limited available evidence supports the use of insulin treatment in CFRD. This fits with the dominant problem in CFRD being insulin deficiency and progressive beta cell dysfunction, making tablets that stimulate the beta cell unlikely to be a successful strategy. It is possible that patients with IGT or CFRD with moderate hyperglycaemia (e.g. relative preservation of fasting glucose) may initially respond to beta cell secretagogues. A large randomized prospective trial in the USA should answer this point in the next few years.

Full Text

The Full Text of this article is available as a PDF (155K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child. 1997 Dec;77(6):493–496. [PMC free article] [PubMed]
  • Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. [PubMed]
  • SHWACHMAN H, LEUBNER H, CATZEL P. Mucoviscidosis. Adv Pediatr. 1955;7:249–323. [PubMed]
  • ROSAN RC, SHWACHMAN H, KULCZVCKI LI. Diabetes mellitus and cystic fibrosis of the pancreas. Laboratory and clinical observations. Am J Dis Child. 1962 Dec;104:625–634. [PubMed]
  • Allen HF, Gay EC, Klingensmith GJ, Hamman RF. Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S. Diabetes Care. 1998 Jun;21(6):943–948. [PubMed]
  • Stutchfield PR, O'Halloran S, Teale JD, Isherwood D, Smith CS, Heaf D. Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child. 1987 Aug;62(8):805–810. [PMC free article] [PubMed]
  • Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ. 1995 Sep 9;311(7006):655–659. [PMC free article] [PubMed]
  • Yung B, Kemp M, Hooper J, Hodson ME. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax. 1999 Jan;54(1):40–43. [PMC free article] [PubMed]
  • De Schepper J, Hachimi-Idrissi S, Smitz J, Dab I, Loeb H. First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters. Horm Res. 1992;38(5-6):260–263. [PubMed]
  • Hardin DS, Moran A. Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin North Am. 1999 Dec;28(4):787–ix. [PubMed]
  • Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW, 3rd, Chesrown SE, Duchow C, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract. 1999 Aug;45(1):61–73. [PubMed]
  • Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child. 2002 Nov;87(5):430–431. [PMC free article] [PubMed]
  • Holl RW, Buck C, Cario H, Wolf A, Thon A, Kohne E, Debatin KM. Diagnosis of diabetes in cystic fibrosis and thalassemia major. Diabetes Care. 1998 Apr;21(4):671–672. [PubMed]
  • Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001 Nov;24(11):1858–1862. [PubMed]
  • Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther. 2000;2 (Suppl 1):S13–S18. [PubMed]
  • Pickup JC, Shaw GW, Claremont DJ. In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer. Diabetologia. 1989 Mar;32(3):213–217. [PubMed]
  • Bantle JP, Thomas W. Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid. J Lab Clin Med. 1997 Oct;130(4):436–441. [PubMed]
  • Gross TM, Mastrototaro JJ. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther. 2000;2 (Suppl 1):S19–S26. [PubMed]
  • Dobson Lee, Sheldon Christopher D, Hattersley Andrew T. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care. 2003 Jun;26(6):1940–1941. [PubMed]
  • Frase LL, Strickland AD, Kachel GW, Krejs GJ. Enhanced glucose absorption in the jejunum of patients with cystic fibrosis. Gastroenterology. 1985 Feb;88(2):478–484. [PubMed]
  • Yung B, Hodson ME. Diabetes in cystic fibrosis. J R Soc Med. 1999;92 (Suppl 37):35–40. [PMC free article] [PubMed]
  • Rodman HM, Doershuk CF, Roland JM. The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine (Baltimore) 1986 Nov;65(6):389–397. [PubMed]
  • Reisman J, Corey M, Canny G, Levison H. Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics. 1990 Sep;86(3):374–377. [PubMed]
  • Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ. Diabetes mellitus associated with cystic fibrosis. J Pediatr. 1988 Mar;112(3):373–377. [PubMed]
  • Culler FL, McKean LP, Buchanan CN, Caplan DB, Meacham LR. Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance. J Pediatr Gastroenterol Nutr. 1994 Apr;18(3):375–378. [PubMed]
  • Chazan BI, Balodimos MC, Holsclaw DS, Shwachman H. Microcirculation in young adults with cystic fibrosis: retinal and conjunctival vascular changes in relation to diabetes. J Pediatr. 1970 Jul;77(1):86–92. [PubMed]
  • Dolan TF., Jr Microangiopathy in a young adult with cystic fibrosis and diabetes mellitus. N Engl J Med. 1986 Apr 10;314(15):991–992. [PubMed]
  • Allen JL. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Engl J Med. 1986 Sep 18;315(12):764–764. [PubMed]
  • Sullivan MM, Denning CR. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics. 1989 Oct;84(4):642–647. [PubMed]
  • Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiøtz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994 Jan;83(1):72–77. [PubMed]
  • Rosenecker J, Höfler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, Posselt HG, Bargon J, von der Hardt H. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res. 2001 Aug 27;6(8):345–350. [PubMed]
  • Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992 Sep;151(9):684–687. [PubMed]
  • Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):891–895. [PubMed]
  • Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr. 2001 Aug;90(8):860–867. [PubMed]
  • Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr. 2001 May;90(5):515–519. [PubMed]
  • Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr. 1994 Aug;83(8):849–853. [PubMed]
  • Lanng S, Thorsteinsson B, Røder ME, Orskov C, Holst JJ, Nerup J, Koch C. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 1993 Mar;128(3):207–214. [PubMed]
  • Miller M, Ward L, Thomas BJ, Cooksley WG, Shepherd RW. Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis. Am J Clin Nutr. 1982 Sep;36(3):492–499. [PubMed]
  • Moran A, Milla C, Ducret R, Nair KS. Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance. Diabetes. 2001 Jun;50(6):1336–1343. [PubMed]
  • Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991 May;118(5):715–723. [PubMed]
  • Hamdi I, Green M, Shneerson JM, Palmer CR, Hales CN. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis. Clin Endocrinol (Oxf) 1993 Jul;39(1):21–26. [PubMed]
  • Cucinotta D, De Luca F, Arrigo T, Di Benedetto A, Sferlazzas C, Gigante A, Rigoli L, Magazzù G. First-phase insulin response to intravenous glucose in cystic fibrosis patients with different degrees of glucose tolerance. J Pediatr Endocrinol. 1994 Jan-Mar;7(1):13–17. [PubMed]
  • Garagorri JM, Rodríguez G, Ros L, Sánchez A. Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. J Pediatr Endocrinol Metab. 2001 Jan;14(1):53–60. [PubMed]
  • Handwerger S, Roth J, Gorden P, Di Sant' Agnese P, Carpenter DF, Peter G. Glucose intolerance in cystic fibrosis. N Engl J Med. 1969 Aug 28;281(9):451–461. [PubMed]
  • Wilmshurst EG, Soeldner JS, Holsclaw DS, Kaufmann RL, Shwachman H, Aoki TT, Gleason RE. Endogenous and exogenous insulin responses in patients with cystic fibrosis. Pediatrics. 1975 Jan;55(1):75–82. [PubMed]
  • Lippe BM, Sperling MA, Dooley RR. Pancreatic alpha and beta cell functions in cystic fibrosis. J Pediatr. 1977 May;90(5):751–755. [PubMed]
  • Cucinotta D, Conti Nibali S, Arrigo T, Di Benedetto A, Magazzù G, Di Cesare E, Costantino A, Pezzino V, De Luca F. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res. 1990;34(1):33–38. [PubMed]
  • Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med. 2002 Mar;19(3):221–226. [PubMed]
  • Redmond AO, Buchanan KD, Trimble ER. Insulin and glucagon response to arginine infusion in cystic fibrosis. Acta Paediatr Scand. 1977 Mar;66(2):199–204. [PubMed]
  • Iannucci A, Mukai K, Johnson D, Burke B. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol. 1984 Mar;15(3):278–284. [PubMed]
  • Kopito LE, Shwachman H. The pancreas in cystic fibrosis: chemical composition and comparative morphology. Pediatr Res. 1976 Aug;10(8):742–749. [PubMed]
  • Löhr M, Goertchen P, Nizze H, Gould NS, Gould VE, Oberholzer M, Heitz PU, Klöppel G. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virchows Arch A Pathol Anat Histopathol. 1989;414(2):179–185. [PubMed]
  • Soejima K, Landing BH. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr Pathol. 1986;6(1):25–46. [PubMed]
  • Abdul-Karim FW, Dahms BB, Velasco ME, Rodman HM. Islets of Langerhans in adolescents and adults with cystic fibrosis. A quantitative study. Arch Pathol Lab Med. 1986 Jul;110(7):602–606. [PubMed]
  • Couce M, O'Brien TD, Moran A, Roche PC, Butler PC. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab. 1996 Mar;81(3):1267–1272. [PubMed]
  • Cucinotta D, De Luca F, Gigante A, Arrigo T, Di Benedetto A, Tedeschi A, Lombardo F, Romano G, Sferlazzas C. No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol. 1994 Mar;130(3):253–258. [PubMed]
  • Lanng S, Thorsteinsson B, Røder ME, Nerup J, Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf) 1994 Aug;41(2):217–223. [PubMed]
  • Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER. Insulin sensitivity in cystic fibrosis. Diabetes. 1994 Aug;43(8):1020–1026. [PubMed]
  • Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab. 1994 Jul;79(1):80–85. [PubMed]
  • Ahmad T, Nelson R, Taylor R. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism. 1994 Feb;43(2):163–167. [PubMed]
  • Taylor CJ, Baxter PS, Hardcastle J, Hardcastle PT, Goldhill J. Glucose intolerance in cystic fibrosis. Arch Dis Child. 1989 May;64(5):759–759. [PMC free article] [PubMed]
  • Zipf WB, Kien CL, Horswill CA, McCoy KS, O'Dorisio T, Pinyerd BL. Effects of tolbutamide on growth and body composition of nondiabetic children with cystic fibrosis. Pediatr Res. 1991 Oct;30(4):309–314. [PubMed]
  • Hinds A, Sheehan AG, Parsons HG. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance. Metabolism. 1995 Jan;44(1):13–18. [PubMed]
  • Rosenecker J, Eichler I, Bärmeier H, von der Hardt H. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol. 2001 Nov;32(5):351–355. [PubMed]
  • Sheppard DN, Welsh MJ. Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol. 1992 Oct;100(4):573–591. [PMC free article] [PubMed]
  • Kentrup H, Bongers H, Spengler M, Kusenbach G, Skopnik H. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance. Eur J Pediatr. 1999 Jun;158(6):455–459. [PubMed]
  • Moran A, Phillips J, Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care. 2001 Oct;24(10):1706–1710. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press